Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
joint venture
Pharma
Gilead's Kite exits China cell therapy JV with Fosun Pharma
Kite’s exit from the Fosun JV comes as CAR-T meds continue to navigate patient access and reimbursement dynamics in China.
Angus Liu
Sep 19, 2024 4:23pm
Plotting plant, National Resilience sets up shop in Saudi Arabia
Aug 29, 2023 8:55am
Kyowa Kirin offloads mature drugs to Grünenthal in Europe
Nov 28, 2022 11:00am
Pfizer plots $16B exit from GSK consumer health JV
Jun 1, 2022 8:20am
AstraZeneca, Takeda, Biogen, Samsung and more—Fierce Pharma Asia
Feb 4, 2022 6:26am
Biogen sells stake in biosim JV to partner Samsung for $2.3B
Jan 28, 2022 8:10am
.jpg?VersionId=eyUxdgRzBMCqcbfCWw0J0Zez5gpCmJ0v)
